Used primarily in pharmaceutical research as a potent and selective antagonist of the serotonin 5-HT2A receptor. It shows promise in the development of treatments for neuropsychiatric disorders such as schizophrenia, depression, and anxiety due to its ability to modulate serotonin signaling without significant dopaminergic activity. Its structure allows for high blood-brain barrier penetration, making it effective in central nervous system applications. Also investigated for potential use in managing insomnia and other sleep disorders linked to serotonin dysregulation. Currently utilized in preclinical studies to explore receptor binding profiles and neurochemical effects in animal models.